Search

Showing total 1,869 results
1,869 results

Search Results

51. Pyrethroid resistance persists after ten years without usage against Aedes aegypti in governmental campaigns: Lessons from São Paulo State, Brazil.

52. Results of a confirmatory mapping tool for Lymphatic filariasis endemicity classification in areas where transmission was uncertain in Ethiopia.

53. Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.

54. An agent-based model of tsetse fly response to seasonal climatic drivers: Assessing the impact on sleeping sickness transmission rates.

55. Caregivers’ views on stigmatization and discrimination of people affected by leprosy in Ghana.

56. Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses.

57. Testing for soil-transmitted helminth transmission elimination: Analysing the impact of the sensitivity of different diagnostic tools.

58. Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.

59. Scabies in the age of increasing drug resistance.

60. Zika virus: An updated review of competent or naturally infected mosquitoes.

61. Structural basis for the high specificity of a Trypanosoma congolense immunoassay targeting glycosomal aldolase.

62. Host outdoor exposure variability affects the transmission and spread of Zika virus: Insights for epidemic control.

63. Spatiotemporal and molecular epidemiology of cutaneous leishmaniasis in Libya.

64. Modeling zoonotic cutaneous leishmaniasis incidence in central Tunisia from 2009-2015: Forecasting models using climate variables as predictors.

65. An economic evaluation of vector control in the age of a dengue vaccine.

66. Development of a set of community-informed Ebola messages for Sierra Leone.

67. Challenges in developing methods for quantifying the effects of weather and climate on water-associated diseases: A systematic review.

68. Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.

69. Associations between selective attention and soil-transmitted helminth infections, socioeconomic status, and physical fitness in disadvantaged children in Port Elizabeth, South Africa: An observational study.

70. Application of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu, India.

71. VivaxGEN: An open access platform for comparative analysis of short tandem repeat genotyping data in Plasmodium vivax Populations.

72. Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria.

73. Developing photoreceptor-based models of visual attraction in riverine tsetse, for use in the engineering of more-attractive polyester fabrics for control devices.

74. Management and modeling approaches for controlling raccoon rabies: The road to elimination.

75. The significant scale up and success of Transmission Assessment Surveys 'TAS' for endgame surveillance of lymphatic filariasis in Bangladesh: One step closer to the elimination goal of 2020.

76. Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.

77. Soluble Egg Antigens of Schistosoma japonicum Induce Senescence of Activated Hepatic Stellate Cells by Activation of the FoxO3a/SKP2/P27 Pathway.

78. A Multi-Host Agent-Based Model for a Zoonotic, Vector-Borne Disease. A Case Study on Trypanosomiasis in Eastern Province, Zambia.

79. The Impact of a Rights-Based Counselling Intervention to Reduce Stigma in People Affected by Leprosy in Indonesia.

80. Quantitative Laser Biospeckle Method for the Evaluation of the Activity of Trypanosoma cruzi Using VDRL Plates and Digital Analysis.

81. Using C. elegans Forward and Reverse Genetics to Identify New Compounds with Anthelmintic Activity.

82. Validation of a Rapid Rabies Diagnostic Tool for Field Surveillance in Developing Countries.

83. Sex-Biased Transcriptome of Schistosoma mansoni: Host-Parasite Interaction, Genetic Determinants and Epigenetic Regulators Are Associated with Sexual Differentiation.

84. Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.

85. Challenges in Real-Time Prediction of Infectious Disease: A Case Study of Dengue in Thailand.

86. Self-Care for Management of Secondary Lymphedema: A Systematic Review.

87. Vestibular Evoked Myogenic Potential (VEMP) Triggered by Galvanic Vestibular Stimulation (GVS): A Promising Tool to Assess Spinal Cord Function in Schistosomal Myeloradiculopathy.

88. Willingness to Pay for Dog Rabies Vaccine and Registration in Ilocos Norte, Philippines (2012).

89. Zika Virus: Medical Countermeasure Development Challenges.

90. Oral Efficacy of Apigenin against Cutaneous Leishmaniasis: Involvement of Reactive Oxygen Species and Autophagy as a Mechanism of Action.

91. Rabies in the Baltic States: Decoding a Process of Control and Elimination.

92. A Colour Opponent Model That Explains Tsetse Fly Attraction to Visual Baits and Can Be Used to Investigate More Efficacious Bait Materials.

93. New Insights in Cysticercosis Transmission.

94. New Developments of RNAi in Paracoccidioides brasiliensis: Prospects for High-Throughput, Genome-Wide, Functional Genomics.

95. Visceral Leishmaniasis in Ethiopia: An Evolving Disease.

96. The Effect of (-)-Epigallocatechin 3-O - Gallate In Vitro and In Vivo in Leishmania braziliensis: Involvement of Reactive Oxygen Species as a Mechanism of Action.

97. Ultraviolet sensitivity of WASH (water, sanitation, and hygiene) -related helminths: A systematic review.

98. Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi.

99. Quantifying the Association between Bovine and Human Trypanosomiasis in Newly Affected Sleeping Sickness Areas of Uganda.

100. Interruption of Infection Transmission in the Onchocerciasis Focus of Ecuador Leading to the Cessation of Ivermectin Distribution.